摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-哌啶甲酸甲酯 | 41994-45-0

中文名称
2-哌啶甲酸甲酯
中文别名
哌啶-2-羧酸甲酯
英文名称
methyl pipecolinate
英文别名
methyl piperidine-2-carboxylate;methyl 2-piperidinecarboxylate;(RS)-2-(methoxycarbonyl)piperidine
2-哌啶甲酸甲酯化学式
CAS
41994-45-0
化学式
C7H13NO2
mdl
MFCD07364347
分子量
143.186
InChiKey
CXQTTWVBUDFUNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    193.8±33.0 °C(Predicted)
  • 密度:
    1.021±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.857
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 安全说明:
    S26,S36
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    室温

SDS

SDS:98582fde659170eb54a9f7669f571acc
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Methyl piperidine-2-carboxylate
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Methyl piperidine-2-carboxylate
CAS number: 41994-45-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H13NO2
Molecular weight: 143.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-哌啶甲酸甲酯 在 sodium tetrahydroborate 、 三乙胺 作用下, 以 四氢呋喃甲醇叔丁醇 为溶剂, 反应 3.5h, 生成 甲基2-(羟基甲基)-1-哌啶羧酸酯
    参考文献:
    名称:
    Derivatives of heterocyclic ?-iminocarboxylic acids. 4. Reduction of N-alkoxycarbonyl derivatives of ?-iminocarboxylic acids
    摘要:
    DOI:
    10.1007/bf00532039
  • 作为产物:
    参考文献:
    名称:
    FeCl 3催化的仲胺,咪唑和吡唑向2-乙酰氨基丙烯酸甲酯的共轭加成反应。β-二烷基氨基-丙氨酸和β-(N-杂芳基)-α-丙氨酸衍生物的制备
    摘要:
    β-二烷基氨基-α-丙氨酸和β-(N-杂芳基)-α-丙氨酸衍生物是通过在铁下将基于氮的亲核试剂(环状和无环仲胺,咪唑和吡唑)共轭添加到2-乙酰氨基丙烯酸甲酯1中而获得的。 (三)氯化物催化。
    DOI:
    10.1016/0040-4020(95)00446-f
  • 作为试剂:
    描述:
    (S)-2-(3,4,5-三甲氧基苯基)丁酸2-哌啶甲酸甲酯2-哌啶甲酸甲酯 作用下, 以90的产率得到[S-(R*,R*)]-1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperdinecarboxylic acid
    参考文献:
    名称:
    [EN] SYNTHETIC DERIVATIVES OF RAPAMYCIN AS MULTIMERIZING AGENTS FOR CHIMERIC PROTEINS WITH IMMUNOPHILIN-DERIVED DOMAINS
    [FR] DERIVES SYNTHETIQUES DE RAPAMYCINE UTILISES COMME AGENTS DE MULTIMERISATION DE PROTEINES CHIMERES A DOMAINES DERIVES DE L'IMMUNOPHILINE
    摘要:
    (中) 揭示了用于多聚免疫蛋白和含有免疫蛋白或免疫蛋白相关域的蛋白质的新化合物。该化合物的化学式为(I): M-L-Q,其已解析立体异构体或一个或多个此类立体异构体的混合物以及其药学上可接受的盐。其中,M是一个免疫蛋白结合基团,包括式(II)的基团;G独立地选择自(a)、(b)和(c)组成的群体;Q包括式(II)的基团、自然存在的大环FKBP配体或其衍生物,或式(III)的合成FKBP配体;n=1或2;X=O、NH或CH2;B1和B2独立地是H或脂肪族、杂脂族、芳基或杂芳基;Y=O、S、NH、-NH(C=O)-、-NH(C=O)-O-、-NH(SO2)-或NR3,或代表从R2到碳9的共价键;R1、R2和R3相同或不同,独立地是脂肪族、杂脂族、芳基或杂芳基;L是一个连接单体M到Q的连接基团,或通过共价键将M1与M2连接起来,通过共价键连接到R1或R2,M1和M2中的每个不一定相同。
    公开号:
    WO1997031898A1
点击查看最新优质反应信息

文献信息

  • Synthesis and Biological Activity of (S)-2-Amino-3(2,5-dihydro-5-oxo-4-isoxazolyl)propanoic Acid (TAN-950 A) Derivatives.
    作者:Norikazu TAMURA、Yoshihiro MATSUSHITA、Toshi IWAMA、Setsuo HARADA、Shoji KISHIMOTO、Katsumi ITOH
    DOI:10.1248/cpb.39.1199
    日期:——
    starting with methyl (S)- and (R)-N-Boc-pyroglutamate (8) via acylation at the C-4 position followed by isoxazolone formation with hydroxylamine and subsequent deprotection reactions. The lactam 16, prepared from (RS)-aminoadipic acid, and dimethyl esters 19 of (R)- and (S)-aspartic acid were converted to (RS)-3-methyl-homo-TAN-950 A (15i) and optically active nor-TAN-950 A derivatives 15j--o, respectively
    (S)-2-氨基-3-(2,5-二氢-5-氧代-4-异恶唑基)丙酸(TAN-950 A(1))是一种新型氨基酸抗生素,对谷氨酸受体具有高亲和力中枢神经系统。为了提高对谷氨酸受体的亲和力,研究了TAN-950 A衍生物6a-o,15a-o的构效关系。以(S)-和(R)-N-Boc-焦谷氨酸甲酯(8)为起始原料,通过C-4位的酰化反应合成旋光性TAN-950 A类似物15a-h,然后与羟胺形成异恶唑酮并随后脱保护反应。将由(RS)-氨基己二酸和(R)-和(S)-天冬氨酸的二甲酯19制备的内酰胺16转化为(RS)-3-甲基-homo-TAN-950 A(15i)和利用相似的反应序列分别对光学活性的nor-TAN-950 A衍生物15j-o进行了研究。大多数TAN-950 A衍生物6a-o,15a-o对谷氨酸受体具有亲和力。3-烷基衍生物15b,d-g特别显示出对喹喹啉亚型受体的高亲和力,并对海马
  • [EN] NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION<br/>[FR] NOUVELLES DIHYDROQUINOLIZINONES POUR LE TRAITEMENT ET LA PROPHYLAXIE D'UNE INFECTION PAR LE VIRUS DE L'HÉPATITE B
    申请人:HOFFMANN LA ROCHE
    公开号:WO2015173164A1
    公开(公告)日:2015-11-19
    The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R6, X and Y are as described in the description and in the claims, as well as or pharmaceutically acceptable salts, or enantiomers, or diastereomers thereof. The invention also contains compositions including the compounds and methods of using the compounds.
    该发明提供了具有以下一般式的新化合物:其中R1、R2、R3、R4、R5、R6、X和Y如描述和权利要求中所述,以及其药学上可接受的盐,或对映体,或非对映异构体。该发明还包括包括这些化合物的组合物和使用这些化合物的方法。
  • Zirconium-hydride-catalyzed site-selective hydroboration of amides for the synthesis of amines: Mechanism, scope, and application
    作者:Bo Han、Jiong Zhang、Haijun Jiao、Lipeng Wu
    DOI:10.1016/s1872-2067(21)63853-6
    日期:2021.11
    diverse amines. Various readily reducible functional groups, such as esters, alkynes, and alkenes, were well tolerated. Furthermore, the methodology was extended to the synthesis of bio- and drug-derived amines. Detailed mechanistic studies revealed a reaction pathway entailing aldehyde and amido complex formation via an unusual C–N bond cleavage-reformation process, followed by C–O bond cleavage.
    开发用于选择性合成胺的温和高效的催化方法是一个长期的研究目标。在这方面,催化脱氧酰胺还原已被证明是有前途但具有挑战性的,因为这种方法需要选择性的 C-O 键裂解。在此,我们报告了伯、仲和叔酰胺在室温下由地球丰富的金属催化剂 Zr-H 催化的选择性硼氢化反应,以获取不同的胺。各种易于还原的官能团,如酯、炔烃和烯烃,都具有良好的耐受性。此外,该方法还扩展到生物和药物衍生胺的合成。详细的机理研究揭示了一个反应途径,通过一个不寻常的 C-N 键断裂-重整过程形成醛和酰胺复合物,然后是 C-O 键断裂。
  • Selective conversion of primary amides to esters promoted by KHSO4
    作者:Narsimha Sattenapally、Jhanvi Sharma、Yuqing Hou
    DOI:10.24820/ark.5550190.p010.392
    日期:——
    Primary amides, either aliphatic or aromatic, are easily converted to the corresponding esters via reflux in lower primary alcohols in the presence of KHSO4. Secondary amides lead to complicated mixtures under analogous conditions, whereas tertiary amides were inert. Use of isopropyl alcohol resulted in the formation of product at slower rate and lower yield along with side products, whereas, use of
    在 KHSO4 存在下,通过在低级伯醇中回流,脂肪族或芳香族伯酰胺很容易转化为相应的酯。仲酰胺在类似条件下会导致复杂的混合物,而叔酰胺是惰性的。异丙醇的使用导致产物的形成速度较慢,产率较低,同时副产物也较低,而使用叔醇不能成功转化,烯丙醇和苯甲醇提供了复杂的混合物。
  • Pseudoephedrine-Directed Asymmetric α-Arylation of α-Amino Acid Derivatives
    作者:Rachel C. Atkinson、Fernando Fernández-Nieto、Josep Mas Roselló、Jonathan Clayden
    DOI:10.1002/anie.201502569
    日期:2015.7.27
    Available α‐amino acids undergo arylation at their α position in an enantioselective manner on treatment with base of N′‐aryl urea derivatives ligated to pseudoephedrine as a chiral auxiliary. In situ silylation and enolization induces diastereoselective migration of the N′‐aryl group to the α position of the amino acid, followed by ring closure to a hydantoin with concomitant explulsion of the recyclable
    可用的α-氨基酸在与连接到假麻黄碱的N'-芳基尿素衍生物的碱作为手性助剂的处理下,以对映选择性的方式在其α位进行芳基化。原位甲硅烷基化和烯醇化诱导N'-芳基向非对映选择性迁移至氨基酸的α位置,随后闭环至乙内酰脲,同时伴随着可回收助剂的爆炸。乙内酰脲产物的水解提供了季氨基酸的衍生物。芳基化避免使用重金属添加剂,并且成功地用于一系列氨基酸和具有不同电子特性的芳基环。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物